期刊文献+

顺铂联合exosomes瘤苗对小鼠H_(22)肝癌移植瘤的治疗作用及机制 被引量:1

Efficacy of cisplatin combined with exosomes tumor vaccine in treatment of mice bearing transplanted H_(22) hepatocarcinoma and its regulatory mechanism
原文传递
导出
摘要 目的:探讨顺铂与Exosomes瘤苗联合应用对小鼠H22肝癌移植瘤的抑制作用及其机制.方法:将接种H22细胞的荷瘤小鼠随机分为对照组,Exosomes瘤苗组,顺铂组,顺铂+Exosomes联合治疗组.15d后处死小鼠,通过称量各小鼠H22移植瘤的质量,计算抑瘤率;电镜观察荷瘤小鼠肿瘤组织超微结构改变;分别称脾质量和胸腺质量,检测荷瘤小鼠脾脏指数和胸腺指数;采用MTT法检测小鼠脾淋巴细胞增殖情况和细胞毒活性;ELISA法检测血清中IL-2,INF-γ的水平.结果:联合治疗组对移植瘤抑制力最强,抑瘤率达64.4%,电镜下可见较为典型的细胞凋亡形态学改变;联合治疗组荷瘤鼠脾指数、胸腺指数分别为(9.96±0.91),(3.51±4.79)mg/g,与对照组相比较明显提高(P<0.01),且脾淋巴细胞增殖能力和细胞毒活性增强(P<0.01);联合治疗组小鼠血清中IL-2,INF-γ水平分别为(421.51±39.17),(39.86±3.15)g/L,与对照组相比差异具有统计学意义(P<0.01).结论:顺铂与Exosomes瘤苗联合应用,能显著抑制小鼠肝癌移植瘤生长,这种作用可能与增强抗肿瘤免疫功能有关. AIM: To investigate the inhibitory activity of cisplatin combined with exosomes tumor vaccine on the growth of transplanted H22 hepatocarcinoma in mice and its regulatory mechanism. METHODS: The mice inoculated with H22 cells were divided into 4 groups at random: control group, exosomes group, cisplatin group and combination group (eisplatin plus exosomes). Fifteen days later, the mice were killed, then the weight of H22 xenograft tumor was measured and the tumor-inhibiting rate was calculated. Transmission electron microscopy (TEM) was used to observe the ultramicro-structure alterations of H22 xenograft tumor tissue in BALB/c mice. The spleens and thymuses were weighed, and the spleen indexes and thymus indexes were determined. The proliferation and cytotoxicity of splenoeytes were detected by MTT assay. Serum levels of IL-2 and INF-γ were detected by ELISA. RESULTS: The inhibitory activity was the most strong in combination group, with the inhibition rate reaching 64.4%. TEM demonstrated the existence of apoptotic cells and apoptotie bodies in H22 xenograft tumor tissues in combination group. The spleen indexes and thymus indexes of mice bearing tumor in combination group were (9.96 ±0.91) and (3.51 ±4.79) mg/g. Compared with control group, the spleen indexes and thymus indexes in combination group were significantly increased ( P 〈 0.01 ), and the proliferation and cytotoxicity of spleen lymphocytes were remarkably enhanced (P 〈 0.01 ). The serum levels of IL-2 and INF-γwere (421.51 ±39.17) and (39.86 ±3.15) g/L in combination group, and the difference was significant compared with the control group (P〈0. 01 ). CONCLUSION: Combination of cisplatin and exosomes exerts strong inhibitory activity on the growth of transplanted H22 hepatocarcinoma in mice. The effect may be correlated to the enhanced immune activity in mice.
出处 《第四军医大学学报》 北大核心 2008年第24期2263-2266,共4页 Journal of the Fourth Military Medical University
关键词 顺铂 EXOSOMES 综合疗法 癌症疫苗 eisplatin exosomes combined modality therapy cancer vaccines
  • 相关文献

参考文献9

  • 1李静,沈宜,汤为学,陈黎,段红.小鼠肝癌细胞H(22)源exosomes的制备及其免疫相关蛋白的初步研究[J].中华肝脏病杂志,2007,15(6):437-440. 被引量:17
  • 2代继宏,王永红,何海霞.Th1/Th2类细胞因子对哮喘大鼠脾淋巴细胞神经生长因子表达的影响[J].第四军医大学学报,2008,29(4):298-301. 被引量:2
  • 3Van Moorsel CJ,Pinedo HM, Veerman G, et al. Scheduling of gemcitabine and cisplatin in Lewis hmg tumor beating mice [ J ]. Eur J Cancer, 1999,35 (5) : 808 - 814.
  • 4Chu Y, Wang LX, Yang G, et al. Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established lewis lung carcinoma [ J ]. J Immunother, 2006, 29 ( 4 ) : 367 - 369.
  • 5Lichtor T, Glick RP, Lin H, et al. Advantages of a unique DNA- based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in mice [ J]. Cancer Ther,2006, 4A: 163 - 170.
  • 6Saji S,Kunieda K, Sugiyama Y. Immunochemotherapy for cancer patients of the stomach-cancer therapy keeping with good host-immunocompetency [ J ]. Nippon Rinsho, 2001,59 ( S4 ) 420 - 426.
  • 7Song CK, Han HD, Noh KH,et al. Chemotherapy enhances CD8 + T cell-mediated antitumor immunity induced by vaccination with vaccinia virus[J]. Mol Ther,2007,15(8) :1558 -1563.
  • 8Mackall CL. T-cell immunodeficieney following cytotoxic antineoplastic therapy [J]. Stem Cells,2000,18( 1 ) :10 - 18.
  • 9秦东春,王海颖,梅园丁,张钦宪.原发性肝细胞癌患者免疫功能的改变[J].第四军医大学学报,2007,28(20):1891-1894. 被引量:4

二级参考文献31

  • 1林敏娟,胡成平,吴鄂生,潘频华.支气管哮喘大鼠肺组织中白血病抑制因子的表达变化[J].中华结核和呼吸杂志,2003,26(11):727-728. 被引量:14
  • 2刘力戈,侯安存,方惠秋,郝艳艳.支气管哮喘患儿血T辅助淋巴细胞的变化[J].实用儿科临床杂志,2006,21(4):217-218. 被引量:26
  • 3司徒镇强 吴军正.细胞培养[M].西安:世界图书版出版公司,2004.78-202.
  • 4Morelli AE, Larregina AT, Shufesky W J, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood, 2004, 104: 3257-3266.
  • 5Young D, Roman E, Moreno C, et al. Molecular chaperones and the immune response. Philos Trans R Soc Lond B Biol Sci, 1993, 339: 363-367.
  • 6Wubbolts R, Leckie RS, Veenhuizen PT, et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem, 2003, 278: 10963-10972.
  • 7Johnstone RM, Mathew A, Mason AB, et al. Exosome formation during maturation of mammalian and avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins. J Cell Physiol, 1991, 147: 27-36.
  • 8Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol, 2002, 2: 569-579.
  • 9Bard MP, Hegmans JE Hemmes A, et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol, 2004, 31: 114-121.
  • 10Hegmans JP, Bard ME Hemmes A, et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol, 2004, 164: 1807-1815.

共引文献20

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部